The U.S. Department of Veterans Affairs has selected Riverrain’s ClearRead CT AI-powered technology as part of its Lung Precision Oncology Program.

February 1, 2024 — Nearly 8,000 veterans are diagnosed with lung cancer each year. Now at-risk veterans will have access to AI-powered CT technology that removes the web of vessels in the chest CT image, allowing radiologists to see clearly and decide confidently.  

The U.S. Department of Veterans Affairs has selected Riverrain’s ClearRead CT AI-powered technology as part of its Lung Precision Oncology Program.  

Automated precision measurements with ClearRead CT lead to improved repeatability and consistency of imaging interpretation across different radiology readers, times of day, and workload. This is important given the alarming levels of radiology burnout and talent shortage. 

Lung cancer is the leading cause of cancer-related death for U.S. veterans. This increased risk is likely due to environmental pollutants and higher smoking rates. The use of this technology by the VA is a step toward addressing health disparities in this population. 

ClearRead CT software is currently installed at 14 of 18 Veterans Integrated Services Networks, with the final 4 VISNs expected to go live in the first quarter of 2024. 

For more information: www.riveraintech.com


Additional Content

News | Radiology Imaging

Nov. 1, 2026 — GE HealthCare recently introduced Allia Celeo,* a ceiling-mounted image guiding system, at the ...

Time November 05, 2026
arrow
News | Radiology Imaging

Nov. 2, 2026 — Neurophet and RapidAI have partnered to integrate Neurophet’s advanced neurodegenerative brain imaging ...

Time November 04, 2026
arrow
News | Ultrasound Imaging

Nov. 3, 2026 — GE HealthCare has announced two new AI-assisted capabilities for its Vscan Air handheld ultrasound system ...

Time November 03, 2026
arrow
News | Ultrasound Imaging

Oct. 28, 2026 — Clarius Mobile Health has announced 30 specialized AI models are now integrated into Clarius App 13.1 ...

Time November 02, 2026
arrow
News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
Subscribe Now